Research work · 2011

IRF4 mutations in chronic lymphocytic leukemia

Violaine Havelange, Yuri Pekarsky, Tatsuya Nakamura, Alexey Palamarchuk, Hansjüerg Alder, Laura Z. Rassenti, Thomas J. Kipps, Carlo Maria Croce

Blood

Abstract

Interferon regulatory factor 4 (IRF4) is a member of the interferon regulatory factor family of transcription factors and has been shown to have critical functions at several stages of B-cell development. Genome-wide association study identified a polymorphism in the 3' untranslated region of IRF4 as a chronic lymphocytic leukemia risk locus. In this study, we report a recurrent heterozygous somatic mutation in the DNA-binding domain of IRF4 detected in 7 of 457 chronic lymphocytic leukemia patients (1.5%). Patients with IRF4 mutation have a good prognosis, and 4 of 6 have a trisomy 12. We also found that IRF4 mRNA expression is higher in the patients with the mutation.

Read free full text

DOI: 10.1182/blood-2011-04-350579